TScan Therapeutics, Inc. (TCRX) Ownership

$2.23

$0.12 (5.69%)
Last update: 04:00 PM EST
Day's range
$2.12
Day's range
$2.28

TScan Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LYNX1 CAPITAL MANAGEMENT LP 08/14/2025 7.86 M $11.39 M   46.66% 6.06%
BVF INC/IL 08/14/2025 5.23 M $7.58 M   6.88% 4.03%
BAKER BROS. ADVISORS LP 08/14/2025 2.78 M $4.04 M   0.00% 2.15%
BLACKROCK, INC. 08/12/2025 2.57 M $3.72 M   -47.39% 1.98%
VANGUARD GROUP INC 08/11/2025 2.15 M $3.12 M   -8.80% 1.66%
PROPEL BIO MANAGEMENT, LLC 08/13/2025 2.09 M $3.03 M   0.00% 1.61%
DEER MANAGEMENT CO. LLC 08/14/2025 1.25 M $1.81 M   0.00% 0.96%
ALPHABET INC. 08/01/2025 1.08 M $1.56 M   0.00% 0.83%
SIMPLIFY ASSET MANAGEMENT INC. 08/07/2025 1.05 M $1.52 M   0.00% 0.81%
ABRDN PLC 07/24/2025 891.45 K $1.29 M   0.00% 0.69%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 792.06 K $1.15 M   366.72% 0.61%
MILLENNIUM MANAGEMENT LLC 08/14/2025 630.14 K $913.70 K   172.58% 0.49%
DC FUNDS, LP 08/14/2025 630.00 K $913.50 K   0.00% 0.49%
TANG CAPITAL MANAGEMENT LLC 08/14/2025 600.00 K $870.00 K   0.00% 0.46%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 566.37 K $821.53 K   -44.20% 0.44%
UBS GROUP AG 08/14/2025 400.40 K $580.58 K   224.37% 0.31%
TWO SIGMA INVESTMENTS, LP 08/14/2025 365.03 K $529.30 K   304.69% 0.28%
JPMORGAN CHASE & CO 08/12/2025 287.74 K $417.23 K   8.54% 0.22%
BANK OF AMERICA CORP /DE/ 08/14/2025 217.97 K $316.05 K   27.95% 0.17%
TWO SIGMA ADVISERS, LP 08/14/2025 214.40 K $310.88 K   337.55% 0.17%
JANE STREET GROUP, LLC 08/14/2025 213.40 K $309.42 K   100.00% 0.16%
STATE STREET CORP 08/14/2025 200.51 K $290.74 K   -75.46% 0.15%
CUBIST SYSTEMATIC STRATEGIES, LLC 08/14/2025 172.51 K $250.14 K   727.79% 0.13%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2025 153.70 K $222.87 K   35.66% 0.12%
TROLUCE CAPITAL ADVISORS LLC 08/14/2025 150.00 K $217.50 K   79.09% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 144.37 K $209.34 K   197.04% 0.11%
BROWN BROTHERS HARRIMAN & CO 08/11/2025 143.05 K $207.42 K   0.00% 0.11%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 129.86 K $188.17 K   -51.92% 0.10%
STIFEL FINANCIAL CORP 08/14/2025 115.94 K $168.11 K   -0.44% 0.09%
NORTHERN TRUST CORP 08/13/2025 98.55 K $142.90 K   -70.14% 0.08%
LETKO, BROSSEAU & ASSOCIATES INC 08/08/2025 95.88 K $139.02 K   24.35% 0.07%
MILITIA CAPITAL PARTNERS, LP 08/14/2025 94.30 K $136.74 K   100.00% 0.07%
NEWEDGE WEALTH, LLC 08/11/2025 91.46 K $150.91 K   0.00% 0.07%
Y-INTERCEPT (HONG KONG) LTD 08/01/2025 76.66 K $111.16 K   100.00% 0.06%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2025 68.29 K $99.02 K   100.00% 0.05%
HRT FINANCIAL LP 08/14/2025 55.37 K $80.00 K   100.00% 0.04%
MARSHALL WACE, LLP 08/13/2025 53.68 K $77.83 K   100.00% 0.04%
JAIN GLOBAL LLC 08/14/2025 37.89 K $54.94 K   100.00% 0.03%
DC INVESTMENTS MANAGEMENT, LLC 08/14/2025 35.56 K $51.57 K   0.00% 0.03%
HSBC HOLDINGS PLC 08/13/2025 30.50 K $44.23 K   -12.96% 0.02%
POINT72 ASIA (SINGAPORE) PTE. LTD. 08/14/2025 29.07 K $42.15 K   100.00% 0.02%
ALGERT GLOBAL LLC 08/14/2025 28.03 K $41.00 K   100.00% 0.02%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2025 24.36 K $35.33 K   50.00% 0.02%
BNP PARIBAS ARBITRAGE, SNC 08/14/2025 23.70 K $34.36 K   -54.29% 0.02%
QUADRATURE CAPITAL LTD 08/13/2025 22.50 K $32.85 K   100.00% 0.02%
SQUAREPOINT OPS LLC 08/27/2025 22.50 K $32.62 K   100.00% 0.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 22.17 K $32.15 K   -80.37% 0.02%
BARCLAYS PLC 08/14/2025 21.18 K $31.00 K   -65.76% 0.02%
NEUBERGER BERMAN GROUP LLC 08/25/2025 21.17 K $30.69 K   100.00% 0.02%
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC 07/25/2025 19.89 K $28.84 K   100.00% 0.02%

TScan Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 112 institutional investors and hedge funds held shares of TScan Therapeutics, Inc.. The most heavily invested institutionals were:

CWM, LLC: 0

Lynx1 Capital Management LP: 7.86 M

BVF INC/IL: 5.23 M

BAKER BROS. ADVISORS LP: 2.78 M

BlackRock, Inc.: 2.57 M

VANGUARD GROUP INC: 2.15 M

26.36% of TScan Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 40.19 M shares in the last 24 months. This purchase volume represents approximately $89.63 M in transactions.